TL;DR — six findings from 8,418 healthcare videos
- Shorts collect 5.8x the median day-30 views of long-form videos (8,720 vs 1,500), but earn fewer subscribers per video (24 vs 41) and roughly one-tenth the subscribers per view.
- Long-form owns authority signals — subscribers gained per finished view, return-viewer rate, and average session watch time all favour long-form by 2-3x.
- The optimal cadence is 2:1 Shorts-to-long-form, with the Shorts explicitly linking to long-form. Channels running this mix grew subscribers 2.4x faster than long-form-only channels.
- Beyond 3:1 the cadence tilts too far. Long-form watch time flattens and the channel becomes a Shorts feed with occasional long-form — which YouTube treats as a Shorts channel and stops surfacing long-form in Watch Next.
- Optimal Short length is 28-42 seconds, with 30 seconds as the operational sweet spot. Under 15 seconds is too shallow; over 55 seconds drops completion below the recommendation threshold.
- Specialty selection matters. Dermatology, hair transplantation, dental and IVF get the biggest Shorts lift. Cardiology and oncology need long-form runway and see thin Shorts benefit.
Cite this report
Inline (HTML):
Ichelon Consulting Group (2026). YouTube Shorts vs Long-Form Healthcare India Study 2026. https://ichelonconsulting.com/reports/youtube-shorts-vs-long-form-healthcare-india-study-2026
APA 7:
Das, D. & Ichelon Consulting Group. (2026). YouTube Shorts vs Long-Form Healthcare India Study 2026: 2,431 Shorts, 5,987 long-form videos compared. Ichelon Consulting Group. https://ichelonconsulting.com/reports/youtube-shorts-vs-long-form-healthcare-india-study-2026
Licence: CC BY 4.0 — free to reuse with attribution.
Six numbers to anchor the study
Methodology
This study aggregates YouTube Data API v3 telemetry from 8,418 videos across 46 Indian healthcare channels tracked in the YODA catalogue between 1 March 2025 and 31 August 2026. Every video was classified by length into Shorts (60 seconds or less, n=2,431), long-form (over 60 seconds, n=5,987), and live/premiere (excluded from this study). Where a channel ran both formats, per-channel paired analysis was used to hold quality and audience factors constant.
Cohort comparison. Because Shorts and long-form use different ranking signals (Shorts feed vs home feed and search), direct per-video comparison is not clean. The study instead compares two things at once: format-level medians across the full sample (what a typical Short earns versus what a typical long-form earns), and per-channel cross-format subscriber attribution (in a channel that ran both, which format drove which subscriber gain).
Cadence cohorts. Channels were bucketed by their long-run Shorts-to-long-form ratio: long-form-only (fewer than 1 Short per 10 long-form), balanced (1:3 to 3:1), Shorts-heavy (over 3:1), and Shorts-only. Subscriber growth was measured over rolling 90-day windows and compared across cohorts.
What this study does not claim. It does not measure production cost. It does not test paid distribution. It does not attribute new patient bookings. All figures describe organic YouTube behaviour under consistent posting.
Finding 1 · Shorts win on reach, long-form wins on subscribers
The numbers: median Short in the sample earned 8,720 views inside 30 days. Median long-form video earned 1,500. That is a 5.8x view-volume advantage. On subscriber conversion, median long-form earned 41 subscribers per video; median Short earned 24 — long-form earns 71 percent more subscribers per video, even though the absolute reach is smaller.
The mechanism is a function of intent surface. A Short lives inside the Shorts feed, where the viewer is browsing rapidly and has already opted into short-attention consumption. A long-form video sits in home feed, Watch Next, and search, where the viewer arrives with a specific question and is prepared to invest time. The specific-question viewer converts to a subscriber at meaningfully higher rates because they are already in a decision-weight moment when they watch.
| Metric | Shorts | Long-form | Advantage |
|---|---|---|---|
| Median day-30 views per video | 8,720 | 1,500 | Shorts +481% |
| Median subscribers gained per video | 24 | 41 | Long-form +71% |
| Subscribers gained per 1,000 views | 2.75 | 27.3 | Long-form 9.9× |
| Completion rate | 68% | 42% | Shorts +26pp |
| Comments per 1,000 views | 0.9 | 1.4 | Long-form +56% |
| Return-viewer rate at 30 days | 11% | 34% | Long-form 3.1× |
Source: YODA catalogue, format-level medians across 8,418 videos, Mar 2025 – Aug 2026.
Finding 2 · The 2:1 cadence is the growth sweet spot
The numbers: channels running a 2:1 Shorts-to-long-form cadence grew subscribers 2.4x faster than long-form-only channels and 1.6x faster than Shorts-only channels over rolling 90-day windows.
The mechanism is a two-lane funnel. Shorts pull discovery — a viewer who has never heard of the practice or the doctor sees a 30-second value proof point in the Shorts feed and clicks the channel avatar. Long-form catches that discovered viewer and converts them from watcher to subscriber. Neither format does both jobs on its own. Long-form-only channels never fill the top of the funnel; Shorts-only channels never close the loop.
Finding 3 · 30 seconds is the operational sweet spot for healthcare Shorts
The numbers: Shorts of 28-42 seconds sustained median completion above 70 percent — the recommendation-eligibility threshold. Under 15 seconds, median completion dropped to 58 percent because the hook, promise and payoff could not compress into the runtime cleanly. Over 55 seconds, median completion fell to 51 percent as viewers swiped away before the payoff.
Healthcare specifics tighten the window further. A dermatology before-after Short at 20 seconds usually feels rushed to the viewer — before-shot, after-shot, cutaway, gone — leaving no space to explain what actually happened. The same Short at 32 seconds gives the clinician enough time to say what the procedure was, what the recovery looked like, and where to see the full walkthrough. That extra context is what converts the viewer from swiper to subscriber.
Finding 4 · Specialty selection determines the Shorts payoff
The numbers: Shorts view-volume advantage over long-form, specialty by specialty — dermatology 8.4x, hair transplantation 7.9x, dental 6.8x, IVF 5.3x, orthopaedics 4.1x, ENT 3.6x, ophthalmology 3.2x, cardiology 2.1x, oncology 1.8x, mental health 3.9x.
Specialties with visually rich, short-form-friendly proof points (before-after, procedure snippet, quick clinical demonstration) collect a compounding Shorts benefit. Specialties whose content demands narrative runway — cardiology explaining a coronary syndrome, oncology explaining a treatment pathway — see the Shorts advantage flatten because a 30-second cardiology Short usually cannot deliver a genuine value payoff. Practices in narrative-heavy specialties should ship fewer Shorts, higher long-form density, and rely on Shorts more selectively.
Finding 5 · Cross-format linking works when the Short is a genuine snippet
The numbers: Shorts that opened with a single value hook and closed with an explicit "see the full explanation on the channel" call-to-action drove 6-9 percent of the linked long-form video's total views. Shorts that told the whole story in 30 seconds drove under 1 percent.
The distinction matters. A Short that gives the answer is a completed transaction — the viewer got what they wanted and has no reason to click through. A Short that opens the answer and defers the resolution creates an information-need pull that the long-form video resolves. In healthcare, the natural pattern is a Short that names the condition and previews the answer ("here is what actually determines your IVF success rate — the two factors most people overlook") and a long-form video that delivers the full 8-12 minute breakdown.
Finding 6 · Shorts do not meaningfully monetise for healthcare programmes
The numbers: the healthcare Shorts revenue share in the catalogue averaged under 4 percent of long-form CPM revenue per 1,000 views. Healthcare topics attract low advertiser competition inside the Shorts revenue pool because health advertisers largely target search and long-form watch pages.
The productive frame for healthcare marketers is to treat Shorts as a marketing-owned discovery investment, not a media-owned revenue channel. The return on Shorts is subscriber growth, brand recall, and top-of-funnel query capture — not direct revenue. Any programme building a business case for Shorts on monetisation alone will not clear the hurdle rate.
What this means for healthcare marketing leaders
Four operating decisions.
1 · Do not choose — run both formats deliberately, at a 2:1 cadence
Shorts alone is discovery without conversion. Long-form alone is authority without reach. Two Shorts per one long-form, with the Shorts explicitly linking to long-form, is the pattern that grows subscribers 2.4x faster than either alone.
2 · Anchor Shorts at 30 seconds, not shorter, not longer
The 28-42 second window sustains completion above the recommendation-eligibility threshold. Rushing under 15 or drifting over 55 both drop the Short out of active recommendation.
3 · Match cadence to specialty
Visually-rich specialties (dermatology, hair transplantation, dental, IVF) should tilt toward 2:1 Shorts-to-long-form. Narrative-heavy specialties (cardiology, oncology) should tilt toward 1:2 in the other direction and use Shorts selectively for the specific angle that compresses well.
4 · Fund Shorts as marketing, not media
The Shorts revenue-sharing pool will not clear the hurdle rate for a healthcare programme. Fund Shorts against subscriber growth, discovery reach, and long-form conversion — the metrics that actually pay back.
Frequently asked — Shorts vs long-form for healthcare
Should a healthcare brand invest in Shorts?
What is the optimal Shorts-to-long-form cadence?
Do Shorts monetise?
How long should healthcare Shorts run?
Which specialties see the biggest lift from Shorts?
Does linking Shorts to long-form actually work?
Related ICG research reports
Want a Shorts-plus-long-form YouTube plan for your practice?
Share your channel URL, or your intent to start one. You will get a specialty-cohort read, a 2:1 shared-calendar sketch, and the first-30-day production plan. No slides, no gated form. Retainers from Rs 20,000/month, custom-scoped per engagement.